![Carmine Stengone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carmine Stengone
Chief Executive Officer at
CONTINEUM THERAPEUTICS, INC.
Net worth: 205 079 $ as of 2026-05-30
Profile
Mr. Carmine N.
Stengone is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-16 | 14,954 ( 0.05% ) | 201 729 $ | 2026-05-30 | |
| 2026-06-09 | 1,250 ( 0.03% ) | 3 350 $ | 2026-05-30 |
Carmine Stengone active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Chief Executive Officer | 2018-09-30 |
| KIORA PHARMACEUTICALS, INC. | Director/Board Member | 2023-07-31 |
Former positions of Carmine Stengone
| Companies | Position | End |
|---|---|---|
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Chief Executive Officer | 2017-12-31 |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Corporate Officer/Principal | 2018-09-30 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 2010-10-27 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Sales & Marketing | 2005-12-31 |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Corporate Officer/Principal | 2003-12-31 |
Training of Carmine Stengone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Commercial Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
- Stock Market
- Insiders
- Carmine Stengone
